Skip to main content
Caroline
Caroline

Dr Caroline Ovadia

Chadburn Clinical Lecturer

Biography

Caroline Ovadia is a Chadburn Clinical Lecturer in Women’s Health at King’s College London, and an Honorary Senior Registrar at Guy’s and St Thomas’ NHS Foundation Trust. She qualified in Medicine from Oxford University in 2005; following clinical rotations in Oxford and Wales, moved to London in 2010 to undertake an Academic Clinical Fellowship at Imperial College London. In 2014, she commenced an NIHR BRC Clinical Research Fellowship in Translational and Experimental Medicine and King’s College London, following which she was awarded Clinical Research Fellowships by Tommy’s Charity and the University of Gothenburg, during which time she completed her PhD. This studied the role of ursodeoxycholic acid treatment in cholestatic pregnancy, under the supervision of Professors Catherine Williamson, Lucy Chappell, and Dr Peter Dixon.

Caroline’s academic interests are in the maternal and fetal influences of metabolic disorders of pregnancy, particularly concentrating on gut-derived endocrine signals and the prevention of adverse perinatal outcomes, including stillbirth. She has published work in major journals, such as the Lancet, Hepatology and the Journal of Clinical Investigation. Clinically, she is undertaking advanced training in maternal medicine and advanced labour ward practice. She is a co-investigator for clinical trials in cholestatic pregnancy and gestational diabetes. Caroline is a member of the British Maternal Fetal Medicine Society and the Society for Endocrinology.

Caroline believes strongly in engaging the public in medicine and science; as such she is a Key Collaborator on contextualising “The Birth Rites” art collection, has spoken at the “Pint of Science” international science festival, undertakes live social media interactive sessions, regularly speaks at schools and is a medical advisor to the charity ICP Support.

Research

williamson-banner
Maternal and Fetal Disease

The Maternal and Fetal Disease Group is led by Professor Catherine Williamson

Preterm birth app_promo
GUARD Trial

GUARD is a Clinical Trial that wants to explore the impact of Ursodeoxycholic Acid (UDCA) compared to metformin in the treatment of Gestational Diabetes Mellitus (GDM).

GUARD MEC Study

In this study we want to find out a bit more about how some medicines affect the gut microbiome in women with gestational diabetes mellitus (GDM).

Project status: Ongoing

News

Impaired liver function during pregnancy may increase risk of childhood obesity

Research from King’s has shown that impaired liver function during pregnancy may alter gut bacteria composition and increase the risk of obesity in children.

pregnant lady

Spotlight

Improving outcomes of high-risk pregnancy

Addressing an unmet meet need for strategies to identify women and babies at risk of serious complications of pregnancy

Maternal health

Research

williamson-banner
Maternal and Fetal Disease

The Maternal and Fetal Disease Group is led by Professor Catherine Williamson

Preterm birth app_promo
GUARD Trial

GUARD is a Clinical Trial that wants to explore the impact of Ursodeoxycholic Acid (UDCA) compared to metformin in the treatment of Gestational Diabetes Mellitus (GDM).

GUARD MEC Study

In this study we want to find out a bit more about how some medicines affect the gut microbiome in women with gestational diabetes mellitus (GDM).

Project status: Ongoing

News

Impaired liver function during pregnancy may increase risk of childhood obesity

Research from King’s has shown that impaired liver function during pregnancy may alter gut bacteria composition and increase the risk of obesity in children.

pregnant lady

Spotlight

Improving outcomes of high-risk pregnancy

Addressing an unmet meet need for strategies to identify women and babies at risk of serious complications of pregnancy

Maternal health